Inventiva SA ADR IVA 深 滬
等待開盤 04-03 09:30:00 美东时间
5.47
+0.040
+0.74%
華盛通- 最 高5.64
- 今 開5.29
- 成交量 32.15万股
- 最 低 5.27
- 昨 收 5.43
- 總市值 11.36亿
- 52周最高 7.9825
- 市盈率 靜 --
- 換手率 0.15%
- 52周最低 2.8536
- 委 比 -50.72%
- 總股本 2.08亿
- 歷史最高 19.064
- 量 比 0.67
- 振 幅 6.81%
- 歷史最低 1.53
- 每 手 1
- 風險率 1.21%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Inventiva says JPMorgan holds 5.99% beneficial stake
Inventiva says JPMorgan holds 5.99% beneficial stake Inventiva disclosed J.P. Morgan Chase dropped below 5% voting rights on March 26, 2026, holding 10.5 million shares. Stake equaled 5.05% of share capital, representing 4.72% of voting rights at that time. J.P. Morgan Chase moved back above 5% voti
04-01 08:09
盘前：纳指期货涨0.94% 特朗普称愿结束战争
周二股市上涨，油价小幅走高，《华尔街曰报》报道称，美国总统特朗普已释放信号，表示他愿意结束美国针对伊朗的军事行动。 截至发稿，道指期货涨1.01%，标普...
03-31 20:30
Inventiva S.A GAAP EPS of -Є1.90, revenue of Є4.5M
Inventiva S.A press release (IVA): FY GAAP EPS of -Є1.90. Revenue of Є4.5M (-51.0% Y/Y). More on Inventiva S.A Inventiva S.A. (IVA) Presents at Barclays 28th Annual Global Healthcare Conference Transc...
03-31 04:19
Inventiva FY EPS $(2.14) Misses $(1.66) Estimate, Sales $5.064M Miss $6.000M Estimate
Inventiva (NASDAQ:IVA) reported quarterly losses of $(2.14) per share which missed the analyst consensus estimate of $(1.66) by 28.92 percent. This is a 35.74 percent increase over losses of $(3.33) per share from the
03-31 04:15
Earnings Scheduled For March 30, 2026
Companies Reporting Before The Bell • Liberty All Star Equity (NYSE:USA) is est...
03-30 19:11
Why Newsmax Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Newsmax Inc (NMAX) shares rose on better-than-expected Q4 results & FY26 sales guidance. Pre-market gainers include ONCO, VSA, GMEX, IZM, GVH, BATL, U, SGML, & GLND. Losers are SLND, DTCX, TOP, SVRN, & GAUZ.
03-27 18:00
J.P. Morgan Chase crosses 5% stake in Inventiva with 5.78% of capital
J.P. Morgan Chase crosses 5% stake in Inventiva with 5.78% of capital JPMorgan Chase reported crossing above the 5% thresholds in Inventiva’s share capital and voting rights through controlled entities. It held 12,001,176 shares, representing 5.78% of the capital and 5.4% of voting rights. Disclaime
03-23 18:12
美股大行评级 | 最高700美元！大摩、瑞银等10家大行集体上调美光目标价；通用磨坊、梅西百货、SailPoint等遭多家大行下调目标价
今日重点评级关注：RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从32美元升至35美元；巴克莱：维持CytomX医疗"超配"评级，目标价从10美元升至16美元
03-20 15:53
Truist Securities Initiates Coverage On Inventiva with Buy Rating, Announces Price Target of $13
Truist Securities analyst Srikripa Devarakonda initiates coverage on Inventiva (NASDAQ:IVA) with a Buy rating and announces Price Target of $13.
03-19 18:12
Inventiva CEO to Join Guggenheim Emerging Outlook Biotech Summit Fireside Chat
Inventiva CEO to Join Guggenheim Emerging Outlook Biotech Summit Fireside Chat Inventiva SA will participate in the Guggenheim Emerging Outlook: Biotech Summit 2026, which takes place on February 11-12, 2026, at the Lotte New York Palace in New York City. CEO Andrew Obenshain is scheduled for a fire
02-05 05:00
